Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -7.29 is 2651% below its 5-year average of -0.26, near the low end of its 5-year range (-10.01–5.02).
As of the fiscal period ended Saturday, August 31, 2024. 7.36% below its 12-month average of -6.79.
Reported quarterly EPS; no daily interpolation.
EPS growth vs the same quarter one year earlier, last 40 quarters.
EARNINGS PER SHARE (EPS)
-7.29
EARNINGS PER SHARE (EPS) AVG TTM
-6.79
EARNINGS PER SHARE (EPS) AVG 3Y
-1.56
EARNINGS PER SHARE (EPS) AVG 5Y
-0.26
EARNINGS PER SHARE (EPS) AVG 10Y
1.56
EARNINGS PER SHARE (EPS) AVG 15Y
3.07
EARNINGS PER SHARE (EPS) AVG 20Y
2.73
CURRENT VS TTM AVG
-7.36%
CURRENT VS 3Y AVG
-366.56%
CURRENT VS 5Y AVG
-2650.94%
CURRENT VS 10Y AVG
-565.95%
CURRENT VS 15Y AVG
-337.13%
CURRENT VS 20Y AVG
-367.19%
Walgreens Boots Alliance, Inc.
Market Cap
$10.37B
Earnings Per Share (EPS)
-7.29
TTM Avg
-6.79
3Y Avg
-1.56
5Y Avg
-0.26
Market Cap
$10.46B
Earnings Per Share (EPS)
0.19
TTM Avg
14.72
3Y Avg
15.46
5Y Avg
14.11
Market Cap
$10.06B
Earnings Per Share (EPS)
23.83
TTM Avg
20.29
3Y Avg
15.04
5Y Avg
13.87
Market Cap
$9.76B
Earnings Per Share (EPS)
3.31
TTM Avg
3.18
3Y Avg
3.37
5Y Avg
3.47
Market Cap
$11.28B
Earnings Per Share (EPS)
0.69
TTM Avg
0.77
3Y Avg
1.27
5Y Avg
1.25
Market Cap
$11.58B
Earnings Per Share (EPS)
-3.76
TTM Avg
-1.35
3Y Avg
4.03
5Y Avg
5.21
Market Cap
$8.95B
Earnings Per Share (EPS)
6.07
TTM Avg
-18.74
3Y Avg
-45.28
5Y Avg
14.90
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Walgreens Boots Alliance, Inc. (WBA) | $10.37B | -7.29 | -6.79 | -1.56 | -0.26 |
| Molina Healthcare, Inc. (MOH)vs › | $10.46B | 0.19 | 14.72 | 15.46 | 14.11 |
| Universal Health Services, Inc. (UHS)vs › | $10.06B | 23.83 | 20.29 | 15.04 | 13.87 |
| Henry Schein, Inc. (HSIC)vs › | $9.76B | 3.31 | 3.18 | 3.37 | 3.47 |
| Bio-Techne Corporation (TECH)vs › | $11.28B | 0.69 | 0.77 | 1.27 | 1.25 |
| Charles River Laboratories International, Inc. (CRL)vs › | $11.58B | -3.76 | -1.35 | 4.03 | 5.21 |
| Insulet Corp. (PODD)vs › | $11.60B | 4.30 | 4.74 | 3.13 | 2.14 |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $8.95B | 6.07 | -18.74 | -45.28 | 14.90 |
| Revvity, Inc. (RVTY)vs › | $12.44B | 2.10 | 2.25 | 2.01 | 3.78 |
| Align Technology, Inc. (ALGN)vs › | $12.58B | 5.96 | 5.64 | 5.43 | 9.01 |
Trailing EPS (TTM)
$-7.29
Forward EPS (Est.)
$1.57
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2024-08-31 | -10.01 |
| 2023-08-31 | -3.57 |
| 2022-08-31 | 5.02 |
| 2021-08-31 | 2.31 |
| 2020-08-31 | 0.52 |
| 2019-08-31 | 4.14 |
| 2018-08-31 | 5.07 |
| 2017-08-31 | 3.80 |
| 2016-08-31 | 3.85 |
| 2015-08-31 | 4.05 |
| 2014-08-31 | 2.03 |
| 2013-08-31 | 2.69 |
| 2012-08-31 | 2.43 |
| 2011-08-31 | 2.97 |
| 2010-08-31 | 2.13 |
| 2009-08-31 | 2.03 |
| 2008-08-31 | 2.18 |
| 2007-08-31 | 2.04 |
| 2006-08-31 | 1.73 |
| 2005-08-31 | 1.53 |
| 2004-08-31 | 1.32 |
| 2003-08-31 | 1.14 |
| 2002-08-31 | 1.00 |
| 2001-08-31 | 0.87 |
| 2000-08-31 | 0.77 |
| 1999-08-31 | 0.62 |
| 1998-08-31 | 0.51 |
| 1997-08-31 | 0.44 |
| 1996-08-31 | 0.38 |
| 1995-08-31 | 0.33 |
